NYSE - Nasdaq Real Time Price USD

Oscar Health, Inc. (OSCR)

Compare
17.96 -0.34 (-1.86%)
At close: September 3 at 4:00 PM EDT
17.72 -0.24 (-1.34%)
After hours: September 3 at 7:59 PM EDT
Loading Chart for OSCR
DELL
  • Previous Close 18.30
  • Open 18.15
  • Bid 17.92 x 900
  • Ask 17.93 x 800
  • Day's Range 17.65 - 18.42
  • 52 Week Range 4.72 - 23.44
  • Volume 2,019,306
  • Avg. Volume 3,144,608
  • Market Cap (intraday) 4.345B
  • Beta (5Y Monthly) 1.61
  • PE Ratio (TTM) --
  • EPS (TTM) -0.15
  • Earnings Date Nov 5, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 24.71

Oscar Health, Inc. operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

www.hioscar.com

2,400

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OSCR

View More

Performance Overview: OSCR

Trailing total returns as of 9/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OSCR
96.28%
S&P 500
15.91%

1-Year Return

OSCR
172.95%
S&P 500
22.44%

3-Year Return

OSCR
1.70%
S&P 500
21.86%

5-Year Return

OSCR
50.11%
S&P 500
44.75%

Compare To: OSCR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OSCR

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    4.43B

  • Enterprise Value

    2.46B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.66

  • Price/Book (mrq)

    3.89

  • Enterprise Value/Revenue

    0.34

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.25%

  • Return on Assets (ttm)

    0.04%

  • Return on Equity (ttm)

    1.74%

  • Revenue (ttm)

    7.23B

  • Net Income Avi to Common (ttm)

    18.15M

  • Diluted EPS (ttm)

    -0.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.63B

  • Total Debt/Equity (mrq)

    31.90%

  • Levered Free Cash Flow (ttm)

    1.15B

Research Analysis: OSCR

View More

Company Insights: OSCR

Research Reports: OSCR

View More

People Also Watch